tradingkey.logo

SINTX Technologies Inc

SINT
查看詳細走勢圖
3.610USD
+0.090+2.56%
收盤 12/19, 16:00美東報價延遲15分鐘
13.05M總市值
虧損本益比TTM

SINTX Technologies Inc

3.610
+0.090+2.56%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+2.56%

5天

-2.17%

1月

+8.08%

6月

+14.60%

今年開始到現在

+3.14%

1年

+2.56%

查看詳細走勢圖

TradingKey SINTX Technologies Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

SINTX Technologies Inc當前公司基本面數據相對健康,增長潛力穩定。當前估值合理,在醫療設備與耗材行業排名143/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價16.00。中期看,股價處於下降通道。近一個月,市場表現較強,但基本面和技術面綜合得分較低,較強的走勢沒有得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

SINTX Technologies Inc評分

相關信息

行業排名
143 / 208
全市場排名
368 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 1 分析師
買入
評級
16.000
目標均價
+280.05%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

SINTX Technologies Inc亮點

亮點風險
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
業績高增長
公司營業收入穩步增長,連續3年增長84.95%
業績增長期
公司處於發展階段,最新年度總收入2.89M美元
估值低估
公司最新PE估值-0.97,處於3年歷史低位
機構加倉
最新機構持股265.99K股,環比增加14.72%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉30.43K股

SINTX Technologies Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

SINTX Technologies Inc簡介

SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
公司代碼SINT
公司SINTX Technologies Inc
CEOOlson (Eric K)
網址https://sintx.com/

常見問題

SINTX Technologies Inc(SINT)的當前股價是多少?

SINTX Technologies Inc(SINT)的當前股價是 3.610。

SINTX Technologies Inc 的股票代碼是什麼?

SINTX Technologies Inc的股票代碼是SINT。

SINTX Technologies Inc股票的52週最高點是多少?

SINTX Technologies Inc股票的52週最高點是7.360。

SINTX Technologies Inc股票的52週最低點是多少?

SINTX Technologies Inc股票的52週最低點是1.710。

SINTX Technologies Inc的市值是多少?

SINTX Technologies Inc的市值是13.05M。

SINTX Technologies Inc的淨利潤是多少?

SINTX Technologies Inc的淨利潤為-11.02M。

現在SINTX Technologies Inc(SINT)的股票是買入、持有還是賣出?

根據分析師評級,SINTX Technologies Inc(SINT)的總體評級為買入,目標價格為16.000。

SINTX Technologies Inc(SINT)股票的每股收益(EPS TTM)是多少

SINTX Technologies Inc(SINT)股票的每股收益(EPS TTM)是-3.739。
KeyAI